Analgetics and psychopharmaceuticals fail, even in high doses, to produce complete pain relief in patients with advanced gynecologic cancer. Due to their side effects, these agents, not totally effective, confine patients to bed and disturb contact with the environment and their families (1). To proceed with destructive neurosurgical methods to provide pain relief in patients with terminal cancer is pointless today (2), because epidural morphine analgesia ( E M ) is capable of improving the quality of the patient’s life in the last stage of cancer (3,4,5). Conventional methods of catheter fixation in patients requiring long-term management with epidural morphine, may, however, cause slight inconvenience to the patient when bathing, and the catheter can be displaced or damaged. To resolve these technical problems, we suggest subcutaneous tunneling of the epidural catheter (6).